GE HealthCare reports strong third-quarter growth and raises 2026 outlook
+1 new source since this summary was written
GE HealthCare reported third-quarter 2026 revenue of $5.5 billion, up 7.2% year over year, with organic growth of 6.2% and adjusted EPS of $1.34. The company lifted full-year adjusted EPS guidance to $4.95-$5.05 from $4.80-$5.00 and increased its organic revenue growth outlook to approximately 4.0% from 3.0%-4.0%. GE HealthCare also reported organic orders growth of 4.0%, a 1.03 times book-to-bill ratio and a $23.7 billion backlog.
Why it matters
The higher guidance raises the earnings and growth outlook for GE HealthCare investors. The company expects adjusted EPS of $4.95-$5.05 and approximately 4.0% organic revenue growth for 2026, up from its prior ranges.
Key facts
- 1Third-quarter revenue was $5.5 billion, representing reported growth of 7.2% and organic growth of 6.2%. stocktitan.net
- 2Diluted EPS was $1.36, while adjusted EPS was $1.34, up 25.1% on an adjusted basis. stocktitan.net
- 3Organic orders increased 4.0%, book-to-bill was 1.03 times and backlog reached $23.7 billion. stocktitan.net
- 4Full-year adjusted EPS guidance increased to $4.95-$5.05 from $4.80-$5.00, while organic revenue growth guidance moved to approximately 4.0% from 3.0%-4.0%. investing.com
- 5GE HealthCare announced plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, with closing expected in the first half of 2027 subject to customary conditions and regulatory approvals. stocktitan.net
Summary written by AlphAI AI Desk from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.